Orgenesis Reports 85% Increase in Revenue and 139% Increase in Gross Profit for Fiscal 2018
Expands POCare platform through a variety of valuable collaboration agreements GERMANTOWN, Md., Feb. 14, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. […]
Expands POCare platform through a variety of valuable collaboration agreements GERMANTOWN, Md., Feb. 14, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. […]
WALTHAM, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the […]
HORSHAM, Pa., Feb. 14, 2019 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, will […]
Results Confirm and Extend 40-Week Findings that Treatment with Crysvita is Superior to Conventional Therapy NOVATO, Calif., TOKYO and LONDON, […]
— FDA Grants Priority Review Status — — Regulatory Action Date is August 19, 2019 — — Golodirsen has been studied […]
— Plazomicin may be well-suited to play a critical role in biodefense preparedness — SOUTH SAN FRANCISCO, Calif., Feb. 14, […]
— Company provides update on ZEMDRI® commercialization and launch — — Data from both the EPIC and CARE Phase 3 clinical studies […]
JENA, Germany, Feb. 14, 2019 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), an innovative biopharmaceutical company developing anti-inflammatory therapeutics by […]
Three Patents, Four Disputed Claim Terms, 100% Win for Finjan, Inc. EAST PALO ALTO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) […]
CALGARY, Alberta, Feb. 14, 2019 (GLOBE NEWSWIRE) — Pan Orient Energy Corp. (“Pan Orient”) (POE – TSXV) is providing an […]